Qianjin Pharmaceutical's first-half net profit rises 41.59% year on year, plans dividend of 1.8 yuan per 10 shares

EarningsCorporate Action
โดย 每日经济新闻·CN·Read original
Summary · why it matters

Qianjin Pharmaceutical disclosed its 2026 half-year report. In the first half, it achieved operating revenue of 1.918 billion yuan, up 5.52% year on year. Net profit attributable to shareholders of the listed company was 181 million yuan, up 41.59% year on year. Basic earnings per share were 0.3674 yuan. The company plans to distribute a cash dividend of 1.8 yuan per 10 shares, tax included. During the reporting period, revenue from the company's pharmaceutical production segment increased.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews